Recital 16, Regulation (EU) 2019/933

In forcesince 20 May 2019

With regard to related acts, if any, prior to the making of a product, or a medicinal product containing that product, the notification should indicate the name of the Member State in which the first related act which would otherwise require the consent of a certificate holder is to take place, as that information is relevant for the timing of the notification.